Replication data for Study of a series of ligands used as inhibitors of the SARS-CoV-2 virus
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'A coronavirus identified in 2019, SARS-CoV-2, has caused a  respiratory illness pandemic called COVID-19. Most people with COVID-19 experience moderate to mild symptoms and do not need special treatments to recover. The SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) has a crucial part in the virus cycle. The active site of the RdRp is a highly accessible area, so focusing on this region to investigate the inhibition of viral replication is an effective therapeutic strategy. The use of pre-existing drugs for the new coronavirus has been proposed by scientists around the world. However, its effectiveness is relatively limited. Other researchers have described the use of available antiviral compounds to reduce the cost and time of new drug development. Therefore, a number of ligands used as SARS-CoV-2 inhibitors have been selected in this ' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["RNA dependent RNA polymerase SARS-CoV-2 virus, COVID-19 treatments, molecular docking, molecular quantum similarity, chemical reactivity descriptors, density functional theory."]} <|eot_id|>
 Here is the Description of a dataset. Description:'A coronavirus identified in 2019, SARS-CoV-2, has caused a  respiratory illness pandemic called COVID-19. Most people with COVID-19 experience moderate to mild symptoms and do not need special treatments to recover. The SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) has a crucial part in the virus cycle. The active site of the RdRp is a highly accessible area, so focusing on this region to investigate the inhibition of viral replication is an effective therapeutic strategy. The use of pre-existing drugs for the new coronavirus has been proposed by scientists around the world. However, its effectiveness is relatively limited. Other researchers have described the use of available antiviral compounds to reduce the cost and time of new drug development. Therefore, a number of ligands used as SARS-CoV-2 inhibitors have been selected in this ' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
A coronavirus identified in 2019, SARS-CoV-2, has caused a  respiratory illness pandemic called COVID-19. Most people with COVID-19 experience moderate to mild symptoms and do not need special treatments to recover. The SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) has a crucial part in the virus cycle. The active site of the RdRp is a highly accessible area, so focusing on this region to investigate the inhibition of viral replication is an effective therapeutic strategy. The use of pre-existing drugs for the new coronavirus has been proposed by scientists around the world. However, its effectiveness is relatively limited. Other researchers have described the use of available antiviral compounds to reduce the cost and time of new drug development. Therefore, a number of ligands used as SARS-CoV-2 inhibitors have been selected in this 
RNA dependent RNA polymerase SARS-CoV-2 virus, COVID-19 treatments, molecular docking, molecular quantum similarity, chemical reactivity descriptors, density functional theory.